Skip to main content
SpringerLink
Log in
Book cover

Principles and Practice of Transplant Infectious Diseases pp 667–677Cite as

Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus, and Human Herpes Viruses 6, 7, and 8 in Transplant Recipients

  • Chapter
  • First Online:

  • 1524 Accesses

Abstract

Human herpes viruses are a family of double-stranded DNA viruses that cause opportunistic infections in solid organ and hematopoietic stem cell transplant recipients. Alpha-herpesviruses cause localized ulcerative mucosal and vesicular cutaneous lesions, with the tendency to disseminate if not treated early and aggressively. Beta-herpes viruses, discussed in this chapter such as human herpes viruses 6 and 7, may rarely cause a febrile illness and a skin rash; however, HHV6 in recipients of allogeneic HSCT is well recognized to cause serious illness including viral hepatitis, encephalitis, and myelosuppression including loss of stem cell graft. The gamma-herpesvirus, HHV-8, causes Kaposi’s sarcoma and body cavity lymphoma, among other rare diseases mostly seen in patients with HIV/AIDS. This chapter will review the epidemiology, clinical diseases, diagnosis, prevention, and treatment of six of the eight members of the human herpesvirus family, including HSV-1, HSV-2, VZV, HHV-6A and HHV-6B, HHV-7, and HHV-8.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Schillinger JA, Xu F, Sternberg MR, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis. 2004;31(12):753.

    Article  PubMed  Google Scholar 

  2. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964.

    Article  CAS  PubMed  Google Scholar 

  3. Wald A, Zeh JE, Selke SA, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342(12):844.

    Article  CAS  PubMed  Google Scholar 

  4. Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jet a. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature. 2013;497:494–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Styczynski J, Reusser P, Einsele H, et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the second European conference on infections in leukemia. Bone Marrow Transplant. 2009;43(10):757.

    Article  CAS  PubMed  Google Scholar 

  6. Greenberg MS, Friedman H, Cohen SG, Oh SH, Laster L, Starr S. A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis. 1987;156(2):280.

    Article  CAS  PubMed  Google Scholar 

  7. Naraqi S, Jackson GG, Jonasson O, Yamashiroya HM. Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts. J Infect Dis. 1977;136(4):531.

    Article  CAS  PubMed  Google Scholar 

  8. Pettersson E, Hovi T, Ahonen J, et al. Prophylactic oral acyclovir after renal transplantation. Transplantation. 1985;39(3):279.

    Article  CAS  PubMed  Google Scholar 

  9. Seale L, Jones CJ, Kathpalia S, et al. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA. 1985;254(24):3435.

    Article  CAS  PubMed  Google Scholar 

  10. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988;158(1):124.

    Article  CAS  PubMed  Google Scholar 

  11. Zuckerman RA, Limaye AP. Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients. Am J Transplant. 2013;13(Suppl 3):55.

    Article  CAS  PubMed  Google Scholar 

  12. Wilck MB, Zuckerman RA. Herpes simplex virus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):121.

    Article  CAS  PubMed  Google Scholar 

  13. Meyers JD, Flournoy N, Thomas ED. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis. 1980;142(3):338.

    Article  CAS  PubMed  Google Scholar 

  14. Tang IY, Maddux MS, Veremis SA, Bauma WD, Pollak R, Mozes MF. Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy. Transplant Proc. 1989;21(1 Pt 2):1758.

    CAS  PubMed  Google Scholar 

  15. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis. 1988;158(1):124.

    Article  CAS  PubMed  Google Scholar 

  16. Basse G, Mengelle C, Kamar N, et al. Disseminated herpes simplex type-2 (HSV-2) infection after solid-organ transplantation. Infection. 2008;36(1):62.

    Article  CAS  PubMed  Google Scholar 

  17. Dummer JS, Armstrong J, Somers J, et al. Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis. 1987;155(2):202.

    Article  CAS  PubMed  Google Scholar 

  18. Goodman JL. Possible transmission of herpes simplex virus by organ transplantation. Transplantation. 1989;47(4):609.

    Article  CAS  PubMed  Google Scholar 

  19. Meyers JD, Wade JC, Mitchell CD, et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med. 1982;73(1A):229.

    Article  CAS  PubMed  Google Scholar 

  20. Spencer GD, Hackman RC, McDonald GB, et al. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation. 1986;42(6):602.

    Article  CAS  PubMed  Google Scholar 

  21. Mommeja-Marin H, Lafaurie M, Scieux C, Galicier L, Oksenhendler E, Molina JM. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis. 2003;37(11):1527.

    Article  PubMed  Google Scholar 

  22. Levitsky J, Duddempudi AT, Lakeman FD, et al. Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl. 2008;1410:1498.

    Article  Google Scholar 

  23. Strick LB, Wald A. Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol Diagn Ther. 2006;10(1):17.

    Article  CAS  PubMed  Google Scholar 

  24. Issa NC, Espy MJ, Uhl JR, Smith TF. Sequencing and resolution of amplified herpes simplex virus DNA with intermediate melting curves as genotype 1 or 2 by LightCycler PCR assay. J Clin Microbiol. 2005;43(4):1843.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Roubalova K, Suchankova A, Vitek A, Sajdova J. Presence of herpes simplex virus (HSV) in peripheral leukocytes of patient who developed active HSV infection after bone marrow transplantation. J Clin Virol. 2000;17(1):37.

    Article  CAS  PubMed  Google Scholar 

  26. Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med. 1981;305(2):63.

    Article  CAS  PubMed  Google Scholar 

  27. Mejias A, Bustos R, Ardura MI, Ramirez C, Sanchez PJ. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. J Perinatol. 2009;29(4):290.

    Article  CAS  PubMed  Google Scholar 

  28. Fluri S, Kaczala GW, Leibundgut K, Alberio L. Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment. Pediatr Emerg Care. 2010;26(12):932.

    Article  PubMed  Google Scholar 

  29. Pergam SA, Limaye AP. Varicella zoster virus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Roque-Afonso AM, Bralet MP, Ichai P, et al. Chickenpox-associated fulminant hepatitis that led to liver transplantation in a 63-year-old woman. Liver Transpl. 2008;14(9):1309.

    Article  PubMed  Google Scholar 

  31. Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis. Transpl Infect Dis. 2008;10(4):260.

    Article  CAS  PubMed  Google Scholar 

  32. Pergam SA, Forsberg CW, Boeckh MJ, et al. Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis. 2011;13(1):15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lauzurica R, Bayes B, Frias C, et al. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc. 2003;35(5):1758.

    Article  CAS  PubMed  Google Scholar 

  34. Alvite-Canosa M, Paniagua-Martin MJ, Quintela-Fandino J, Otero A, Crespo-Leiro MG. Fulminant hepatic failure due to varicella zoster in a heart transplant patient: successful liver transplant. J Heart Lung Transplant. 2009;28(11):1215.

    Article  PubMed  Google Scholar 

  35. Ishizaki Y, Tezuka J, Ohga S, et al. Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella. J Infect. 2003;47(2):133.

    Article  PubMed  Google Scholar 

  36. Watzinger F, Suda M, Preuner S, et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42(11):5189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Razonable RR, Zerr DM. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009;9. Suppl 4:S97.

    Article  PubMed  Google Scholar 

  38. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005;352(8):768.

    Article  CAS  PubMed  Google Scholar 

  39. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med. 1992;326(22):1445.

    Article  CAS  PubMed  Google Scholar 

  40. Caserta MT, Hall CB, Schnabel K, Long CE, D’Heron N. Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr. 1998;133(3):386.

    Article  CAS  PubMed  Google Scholar 

  41. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis. 2002;185(1):110.

    Article  PubMed  Google Scholar 

  42. Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2012;22(3):144–55. Epub 2011 Nov 4

    Article  CAS  PubMed  Google Scholar 

  43. Lee SO, Brown RA, Eid AJ, Razonable RR. Chromosomally integrated human herpesvirus-6 in kidney transplant recipients. Nephrol Dial Transplant. 2011;26(7):2391.

    Article  CAS  PubMed  Google Scholar 

  44. Lee SO, Brown RA, Razonable RR. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation. 2011;92(2):224.

    Article  PubMed  Google Scholar 

  45. Lee SO, Brown RA, Razonable RR. Chromosomally integrated human herpesvirus-6 in transplant recipients. Transpl Infect Dis. 2012;14(4):346–54.

    Article  CAS  PubMed  Google Scholar 

  46. Lautenschlager I, Razonable RR. Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review. Transpl Int. 2012;25(5):493.

    Article  PubMed  Google Scholar 

  47. Potenza L, Luppi M, Barozzi P, et al. HHV-6A in syncytial giant-cell hepatitis. N Engl J Med. 2008;359(6):593.

    Article  CAS  PubMed  Google Scholar 

  48. Feldstein AE, Razonable RR, Boyce TG, et al. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant. 2003;7(2):125.

    Article  PubMed  Google Scholar 

  49. Ljungman P, de la Camara R, Cordonnier C, et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant. 2008;42(4):227.

    Article  CAS  PubMed  Google Scholar 

  50. Cervera C, Marcos MA, Linares L, et al. A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients. Transplantation. 2006;82(7):979.

    Article  PubMed  Google Scholar 

  51. Humar A, Kumar D, Caliendo AM, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation. 2002;73(4):599.

    Article  PubMed  Google Scholar 

  52. Razonable RR, Rivero A, Brown RA, et al. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant. 2003;17(2):114.

    Article  PubMed  Google Scholar 

  53. Zerr DM, Gooley TA, Yeung L, et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001;33(6):763.

    Article  CAS  PubMed  Google Scholar 

  54. Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis. 1999;28(3):562.

    Article  CAS  PubMed  Google Scholar 

  55. Nash PJ, Avery RK, Tang WH, Starling RC, Taege AJ, Yamani MH. Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant. 2004;4(7):1200.

    Article  PubMed  Google Scholar 

  56. Vinnard C, Barton T, Jerud E, Blumberg E. A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl. 2009;15(10):1242.

    Article  PubMed  Google Scholar 

  57. Ljungman P, Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol. 2000;111(3):774.

    CAS  PubMed  Google Scholar 

  58. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation. 1995;60(11):1355.

    CAS  PubMed  Google Scholar 

  59. Randhawa PS, Jenkins FJ, Nalesnik MA, et al. Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation in bile ductular and gastroduodenal epithelium. Am J Surg Pathol. 1997;21(7):847.

    Article  CAS  PubMed  Google Scholar 

  60. Delbridge MS, Karim MS, Shrestha BM, McKane W. Colitis in a renal transplant patient with human herpesvirus-6 infection. Transpl Infect Dis. 2006;8(4):226.

    Article  CAS  PubMed  Google Scholar 

  61. Rossi C, Delforge ML, Jacobs F, et al. Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient. Transplantation. 2001;71(2):288.

    Article  CAS  PubMed  Google Scholar 

  62. Dockrell DH, Prada J, Jones MF, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis. 1997;176(5):1135.

    Article  CAS  PubMed  Google Scholar 

  63. Mendez JC, Dockrell DH, Espy MJ, et al. Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis. 2001;183(2):179.

    Article  CAS  PubMed  Google Scholar 

  64. Dockrell DH, Mendez JC, Jones M, et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation. 1999;67(3):399.

    Article  CAS  PubMed  Google Scholar 

  65. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis. 1998;26(3):702.

    Article  CAS  PubMed  Google Scholar 

  66. Singh N, Husain S, Carrigan DR, et al. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transpl. 2002;16(2):92.

    Article  Google Scholar 

  67. Jacobs F, Knoop C, Brancart F, et al. Human herpesvirus-6 infection after lung and heart-lung transplantation: a prospective longitudinal study. Transplantation. 2003;75(12):1996.

    Article  PubMed  Google Scholar 

  68. Rogers J, Rohal S, Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000;69(12):2566.

    Article  CAS  PubMed  Google Scholar 

  69. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013;13(Suppl 3):67.

    Article  CAS  PubMed  Google Scholar 

  70. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis. 2005;192(8):1331.

    Article  PubMed  Google Scholar 

  71. Manuel O, Kumar D, Moussa G, et al. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis. Transplantation. 2009;87(5):719.

    Article  PubMed  Google Scholar 

  72. Neurohr C, Huppmann P, Leuchte H, et al. Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am J Transplant. 2005;5(12):2982.

    Article  CAS  PubMed  Google Scholar 

  73. Rapaport D, Engelhard D, Tagger G, Or R, Frenkel N. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis. 2002;4(1):10.

    Article  CAS  PubMed  Google Scholar 

  74. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr. 1994;125(1):1.

    Article  CAS  PubMed  Google Scholar 

  75. Wyatt LS, Rodriguez WJ, Balachandran N, Frenkel N. Human herpesvirus 7: antigenic properties and prevalence in children and adults. J Virol. 1991;65(11):6260.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Suga S, Yoshikawa T, Nagai T, Asano Y. Clinical features and virological findings in children with primary human herpesvirus 7 infection. Pediatrics. 1997;99(3):E4.

    Article  CAS  PubMed  Google Scholar 

  77. Yoshikawa T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant. 2003;7(1):11.

    Article  CAS  PubMed  Google Scholar 

  78. Anton A, Cervera C, Pumarola T, et al. Human herpesvirus 7 primary infection in kidney transplant recipients. Transplantation. 2008;85(2):298.

    Article  PubMed  Google Scholar 

  79. Ward KN, White RP, Mackinnon S, Hanna M. Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. Bone Marrow Transplant. 2002;30(12):983.

    Article  CAS  PubMed  Google Scholar 

  80. Tong CY, Bakran A, Williams H, Cheung CY, Peiris JS. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation. 2000;70(1):213.

    CAS  PubMed  Google Scholar 

  81. Griffiths PD, Ait-Khaled M, Bearcroft CP, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol. 1999;59(4):496.

    Article  CAS  PubMed  Google Scholar 

  82. Fernandez C, Boutolleau D, Manichanh C, Mangeney N, Agut H, Gautheret-Dejean A. Quantitation of HHV-7 genome by real-time polymerase chain reaction assay using MGB probe technology. J Virol Methods. 2002;106(1):11.

    Article  CAS  PubMed  Google Scholar 

  83. Yoshida M, Yamada M, Tsukazaki T, et al. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antivir Res. 1998;40(1–2):73.

    Article  CAS  PubMed  Google Scholar 

  84. Brennan DC, Storch GA, Singer GG, Lee L, Rueda J, Schnitzler MA. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis. 2000;181(5):1557.

    Article  CAS  PubMed  Google Scholar 

  85. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865.

    Article  CAS  PubMed  Google Scholar 

  86. Ariza-Heredia EJ, Razonable RR. Human herpes virus 8 in solid organ transplantation. Transplantation. 2011;92(8):837.

    Article  PubMed  Google Scholar 

  87. Butler LM, Were WA, Balinandi S, et al. Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis. 2011;203(5):625.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med. 2000;343(19):1378.

    Article  CAS  PubMed  Google Scholar 

  89. Freitas RB, Freitas MR, Linhares AC. Prevalence of human herpesvirus 8 antibodies in the population of Belem, Para, Brazil. Rev Inst Med Trop Sao Paulo. 2002;44(6):309.

    Article  PubMed  Google Scholar 

  90. Chen N, Nelson KE, Jenkins FJ, et al. Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin Infect Dis. 2004;39(7):1052.

    Article  PubMed  Google Scholar 

  91. Andreoni M, Sarmati L, Nicastri E, et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA. 2002;287(10):1295.

    Article  PubMed  Google Scholar 

  92. Pauk J, Huang ML, Brodie SJ, et al. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343(19):1369.

    Article  CAS  PubMed  Google Scholar 

  93. Vieira J, Huang ML, Koelle DM, Corey L. Transmissible Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi’s sarcoma. J Virol. 1997;71(9):7083.

    CAS  PubMed  PubMed Central  Google Scholar 

  94. Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis. 1998;177(1):213.

    Article  CAS  PubMed  Google Scholar 

  95. Wang QJ, Jenkins FJ, Jacobson LP, et al. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood. 2001;97(8):2366.

    Article  CAS  PubMed  Google Scholar 

  96. Boulanger E, Afonso PV, Yahiaoui Y, Adle-Biassette H, Gabarre J, Agbalika F. Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin. Am J Transplant. 2008;8(3):707.

    Article  CAS  PubMed  Google Scholar 

  97. Di Benedetto F, Di Sandro S, De Ruvo N, et al. Kaposi’s sarcoma after liver transplantation. J Cancer Res Clin Oncol. 2008;134(6):653.

    Article  PubMed  Google Scholar 

  98. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood. 2000;96(9):3279.

    CAS  PubMed  Google Scholar 

  99. Marcelin AG, Roque-Afonso AM, Hurtova M, et al. Fatal disseminated Kaposi’s sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients. Liver Transpl. 2004;10(2):295.

    Article  PubMed  Google Scholar 

  100. Regamey N, Tamm M, Wernli M, et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med. 1998;339(19):1358.

    Article  CAS  PubMed  Google Scholar 

  101. Wasywich CA, Croxson MC, van Doornum GJ, Coverdale HA, Ruygrok PN. Sirolimus for Kaposi’s sarcoma. J Heart Lung Transplant. 2006;25(6):726.

    Article  PubMed  Google Scholar 

  102. Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med. 2003;9(5):554.

    Article  CAS  PubMed  Google Scholar 

  103. Farge D. Kaposi’s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med. 1993;2(6):339.

    CAS  PubMed  Google Scholar 

  104. Qunibi W, Akhtar M, Sheth K, et al. Kaposi’s sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med. 1988;84(2):225.

    Article  CAS  PubMed  Google Scholar 

  105. Ahmadpoor P, Ilkhanizadeh B, Sharifzadeh P, et al. Seroprevalence of human herpes virus-8 in renal transplant recipients: a single center study from Iran. Transplant Proc. 2007;39(4):1000.

    Article  CAS  PubMed  Google Scholar 

  106. Cattani P, Capuano M, Graffeo R, et al. Kaposi’s sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001;39(2):506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342(14):1027.

    Article  CAS  PubMed  Google Scholar 

  108. Farge D, Lebbe C, Marjanovic Z, et al. Human herpes virus-8 and other risk factors for Kaposi’s sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d’ Ile de France (GCIF). Transplantation. 1999;67(9):1236.

    Article  CAS  PubMed  Google Scholar 

  109. Babel N, Eibl N, Ulrich C, et al. Development of Kaposi’s sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod. Transpl Infect Dis. 2008;10(1):59.

    Article  CAS  PubMed  Google Scholar 

  110. Dudderidge TJ, Khalifa M, Jeffery R, Amlot P, Al-Akraa M, Sweny P. Donor-derived human herpes virus 8-related Kaposi’s sarcoma in renal allograft ureter. Transpl Infect Dis. 2008;10(3):221.

    Article  CAS  PubMed  Google Scholar 

  111. Lebbe C, Legendre C, Frances C. Kaposi sarcoma in transplantation. Transplant Rev. 2008;22(4):252.

    Article  Google Scholar 

  112. Martinez S, McAdams HP, Youens KE. Kaposi sarcoma after bilateral lung transplantation. J Thoracic Imaging. 2008;23(1):50.

    Article  Google Scholar 

  113. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia. 1999;13(5):664.

    Article  CAS  PubMed  Google Scholar 

  114. Luppi M, Barozzi P, Rasini V, et al. Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet. Transplantation. 2002;74(1):131.

    Article  PubMed  Google Scholar 

  115. Regamey N, Hess V, Passweg J, et al. Infection with human herpesvirus 8 and transplant-associated gammopathy. Transplantation. 2004;77(10):1551.

    Article  PubMed  Google Scholar 

  116. Laney AS, Peters JS, Manzi SM, Kingsley LA, Chang Y, Moore PS. Use of a multiantigen detection algorithm for diagnosis of Kaposi’s sarcoma-associated herpesvirus infection. J Clin Microbiol. 2006;44(10):3734.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Spira TJ, Lam L, Dollard SC, et al. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol. 2000;38(6):2174.

    CAS  PubMed  PubMed Central  Google Scholar 

  118. Pellet C, Chevret S, Frances C, et al. Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis. 2002;186(1):110.

    Article  PubMed  Google Scholar 

  119. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi’s sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol. 1994;14(2):121.

    Article  CAS  PubMed  Google Scholar 

  120. Kolhe N, Mamode N, Van der Walt J, Pattison J. Regression of post-transplant Kaposi’s sarcoma using sirolimus. Int J Clin Pract. 2006;60(11):1509.

    Article  CAS  PubMed  Google Scholar 

  121. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352(13):1317.

    Article  CAS  PubMed  Google Scholar 

  122. Al Otaibi T, Al Sagheir A, Ludwin D, Meyer R. Post renal transplant Castleman’s disease resolved after graft nephrectomy: a case report. Transplant Proc. 2007;39(4):1276.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, and the William J. von Liebig Center for Transplantation and Clinical Regeneration, College of Medicine, Mayo Clinic, Rochester, MN, USA

    Raymund R. Razonable

Authors
  1. Raymund R. Razonable
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymund R. Razonable .

Editor information

Editors and Affiliations

  1. Clinical Associate Professor of Medicine, Texas Tech University Health Sciences Center El Paso, Paul L. Foster School of Medicine, El Paso, TX, USA

    Amar Safdar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Razonable, R.R. (2019). Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus, and Human Herpes Viruses 6, 7, and 8 in Transplant Recipients. In: Safdar, A. (eds) Principles and Practice of Transplant Infectious Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-9034-4_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9034-4_39

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-9032-0

  • Online ISBN: 978-1-4939-9034-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation